Skip to main content
Product News, Studies & Articles | GileadPro
Other Languages
Login
About Us
Go Back
About Us
Working in Partnership
Swiss Fellowship Program
Research Support Programs
Therapy Areas
Go Back
Therapy Areas
HIV
Liver
Oncology
COVID-19
Invasive Fungal Disease (IFD)
Products
Go Back
Products
HIV
Liver
Oncology
CAR T
COVID-19
Invasive Fungal Diseases (IFDs)
Events
Go Back
Events
Upcoming Events
Past Events
Resources
Go Back
Resources
Congress & Product Updates
Our Clinical Trials
Medical Information
Materials Ordering
Search
Other Languages
Login
Home
Product News, Studies & Articles
Product News, Studies & Articles
Oncology, Hematology & CAR-T
Product News, Studies & Articles
Novel Therapies for Metastatic Triple-Negative Breast Cancer: ...
Mon, 31 May 2021, 12:30 AM
Monday, 31 May 2021 12:30 AM
Triple-negative breast cancer (TNBC) is a biologically heterogeneous disease that is often associated with worse...
ImmunityBio (IBRX) Announces FDA Authorizes its Study of Ankti...
Tue, 15 Jun 2021, 12:30 AM
Tuesday, 15 June 2021 12:30 AM
Open-label Phase 1b/2 study will evaluate the safety and preliminary efficacy of Anktiva (N-803) and PD-L1 t-haN...
Moving Towards Targeted Therapies for Triple-Negative Breast C...
Mon, 07 Jun 2021, 12:30 AM
Monday, 07 June 2021 12:30 AM
In this review, we discuss targets of interest in triple-negative breast cancer (TNBC), approved targeted agents...
Load More
